Webinar: HCV Pretreatment Evaluation
![slide01 HCV Pretreatment Evaluation](https://www.seaetc.com/wp-content/uploads/2016/10/Slide01.jpg)
Facilitated by Mary Hopkins, MD
Assistant Professor, Infectious Diseases
Vanderbilt University School of Medicine
October 5, 2016
Other Trainings
- Webinar: Hepatitis A-E
- Webinar: HCV Treatment in 2016: Genotypes 1, 2, and 3
- Webinar: HIV/HCV/HBV Co-infection
- Webinar: HIV/HBV/HCV co-infection
- Webinar: Emergency Department Testing Unmasks the Hidden Faces of the HCV Epidemic & Identifies Communities at Risk for an Outbreak of HIV Among Persons Who Inject Drugs
Objectives
- Describe how to evaluate likelihood of disease progression
- Discuss importance of and methods for staging liver disease
- Explain how to assess patient readiness for treatment
- Summarize key aspects of pretreatment counseling
Presentation
Slides
![slide01 HCV Pretreatment Evaluation](https://www.seaetc.com/wp-content/uploads/2016/10/Slide01.jpg)
Facilitated by Mary Hopkins, MD
Assistant Professor, Infectious Diseases
Vanderbilt University School of Medicine
October 5, 2016
Objectives
- Describe how to evaluate likelihood of disease progression
- Discuss importance of and methods for staging liver disease
- Explain how to assess patient readiness for treatment
- Summarize key aspects of pretreatment counseling
Presentation
Slides
Other Trainings
- Webinar: Hepatitis A-E
- Webinar: HCV Treatment in 2016: Genotypes 1, 2, and 3
- Webinar: HIV/HCV/HBV Co-infection
- Webinar: HIV/HBV/HCV co-infection
- Webinar: Emergency Department Testing Unmasks the Hidden Faces of the HCV Epidemic & Identifies Communities at Risk for an Outbreak of HIV Among Persons Who Inject Drugs
![slide01 HCV Pretreatment Evaluation](https://www.seaetc.com/wp-content/uploads/2016/10/Slide01.jpg)
Facilitated by Mary Hopkins, MD
Assistant Professor, Infectious Diseases
Vanderbilt University School of Medicine
October 5, 2016
Objectives
- Describe how to evaluate likelihood of disease progression
- Discuss importance of and methods for staging liver disease
- Explain how to assess patient readiness for treatment
- Summarize key aspects of pretreatment counseling
Presentation
Slides
Other Trainings
- Webinar: Hepatitis A-E
- Webinar: HCV Treatment in 2016: Genotypes 1, 2, and 3
- Webinar: HIV/HCV/HBV Co-infection
- Webinar: HIV/HBV/HCV co-infection
- Webinar: Emergency Department Testing Unmasks the Hidden Faces of the HCV Epidemic & Identifies Communities at Risk for an Outbreak of HIV Among Persons Who Inject Drugs